The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Open accessAbstract
Kaposi sarcoma (KS) is a virus-related malignancy which most frequently arises in skin, though visceral sites can also be involved. Infection with Kaposi sarcoma herpes virus (KSHV or HHV-8) is required for development of KS. Nowadays, most cases worldwide occur in persons who are immunosuppressed, usually because of HIV infection or as a result of therapy to combat rejection of a transplanted organ, but classic Kaposi sarcoma is predominantly a disease of the elderly without apparent immunosuppression. We analyzed 2667 KS incident cases diagnosed during 1995-2002 and registered by 75 population-based European cancer registries contributing to the RARECARE project. Total crude and age-standardized incidence rate was 0.3 per 100,000 per year with an estimated 1642 new cases per year in the EU27 countries. Age-standardized incidence rate was 0.8 per 100,000 in Southern Europe but below 0.3 per 100,000 in all other regions. The elevated rate in southern Europe was attributable to a combination of classic Kaposi sarcoma in some Mediterranean countries and the relatively high incidence of AIDS in several countries. Five-year relative survival for 2000-2002 by the period method was 75%. More than 10,000 persons were estimated to be alive in Europe at the beginning of 2008 with a past diagnosis of KS. The aetiological link with suppressed immunity means that many people alive following diagnosis of KS suffer comorbidity from a pre-existing condition. While KS is a rare cancer, it has a relatively good prognosis and so the number of people affected by it is quite large. Thus it provides a notable example of the importance of networking in diagnosis, therapy and research for rare cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
IARC monographs on the evaluation of carcinogenic risks to humans
Hopkins, J. (1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90054-9 · Cited by 2,876
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
Nilsson, B., Bümming, P., Meis‐Kindblom, J. M., Odén, A., Dortok, A., Gustavsson, B., Sablinska, K., & Kindblom, L. (2005) · Cancer · doi:10.1002/cncr.20862 · Cited by 1,272
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
Sant, M., Allemani, C., Santaquilani, M., Knijn, A., Marchesi, F., & Capocaccia, R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.018 · Cited by 1,021
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24320 · Cited by 791
Toro, J. R., Travis, L. B., Wu, H. J., Zhu, K., Fletcher, C. D. M., & Devesa, S. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22239 · Cited by 680
Mechanisms of sarcoma development
Helman, L. J., & Meltzer, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1168 · Cited by 460
Cancer Survival Corrected for Heterogeneity in Patient Withdrawal
Hakulinen, T. (1982) · Biometrics · doi:10.2307/2529873 · Cited by 453
Ancelle, R. A., & Brunet, J. B. (2015) · Antibiotics and Chemotherapy · doi:10.1159/000414218 · Cited by 405
Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database
Giuffrida, A. Y., Burgueno, J. E., Koniaris, L. G., Gutierrez, J. C., Duncan, R., & Scully, S. P. (2009) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/jbjs.h.00416 · Cited by 386
Ferrari, A., Sultan, I., Huang, T. T., Rodriguez‐Galindo, C., Shehadeh, A., Meazza, C., Ness, K. K., Casanova, M., & Spunt, S. L. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23252 · Cited by 376
An alternative approach to monitoring cancer patient survival
Brenner, H., & Gefeller, O. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961101)78:9<2004::aid-cncr23>3.0.co;2-# · Cited by 360
Tryggvason, G., Gíslason, H. G., Magnússon, M. K., & Jónasson, J. G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21167 · Cited by 358
Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases
Rouhani, P., Fletcher, C. D. M., Devesa, S. S., & Toro, J. R. (2008) · Cancer · doi:10.1002/cncr.23571 · Cited by 342
Study, T. S. H. C., Franceschi, S., Lise, M., Clifford, G. M., Rickenbach, M., Levi, F., Maspoli, M., Bouchardy, C., Dehler, S., Jundt, G., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605756 · Cited by 307
Self-citationConcise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn001 · Cited by 307
Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study
Goettsch, W. G., Bos, S. D., Breekveldt-Postma, N., Casparie, M., Herings, R. M. C., & Hogendoorn, P. C. W. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.009 · Cited by 291
Stiller, C. A., Bielack, S. S., Jundt, G., & Steliarova-Foucher, E. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.015 · Cited by 283
Self-citationPhase II Study of Imatinib in Advanced Chordoma
Stacchiotti, S., Longhi, A., Ferraresi, V., Grignani, G., Comandone, A., Stupp, R., Bertuzzi, A., Tamborini, E., Pilotti, S., Messina, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.3656 · Cited by 276
Ray-Coquard, I., Thiesse, P., Ranchère-Vince, D., Chauvin, F., Bobin, J.-Y., Sunyach, M.-P., Carret, J.-P., Mongodin, B., Marec-Bérard, P., Philip, T., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh058 · Cited by 214
Mixture models for cancer survival analysis: application to population-based data with covariates
De Angelis, R., Capocaccia, R., Hakulinen, T., Soderman, B., & Verdecchia, A. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990228)18:4<441::aid-sim23>3.0.co;2-m · Cited by 207
Cook-Mozaffari, P., Newton, R., Beral, V, & Burkitt, D. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.717 · Cited by 204
Choosing the relative survival method for cancer survival estimation
Hakulinen, T., Seppä, K., & Lambert, P. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.011 · Cited by 167
HIV AIDS surveillance in Europe
(n.d.) · RWTH Publications (RWTH Aachen) · Cited by 163
Treatments for classic Kaposi sarcoma: A systematic review of the literature
Regnier-Rosencher, E., Guillot, B., & Dupin, N. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.04.018 · Cited by 129
Survival of children with bone sarcoma in Europe since 1978
Stiller, C. A., Craft, A. W., & Corazziari, I. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00004-1 · Cited by 122
Self-citationSurvival of children with soft-tissue sarcoma in Europe since 1978
Stiller, C. A., Stevens, M. C. G., Magnani, C., & Corazziari, I. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00007-7 · Cited by 114
Self-citationMeasuring cancer prevalence in Europe: the EUROPREVAL Project
Capocaccia, R., Colonna, M., Corazziari, I., Angelis, R. D., Francisci, S., Micheli, A., & Mugno, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf152 · Cited by 105
ESTIMATING THE COMPLETENESS OF PREVALENCE BASED ON CANCER REGISTRY DATA
Capocaccia, R., & Angelis, R. D. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970228)16:4<425::aid-sim414>3.0.co;2-z · Cited by 104
HHV-8 seroprevalence: a global view
Rohner, E., Wyss, N., Trelle, S., Mbulaiteye, S. M., Egger, M., Novak, U., Zwahlen, M., & Bohlius, J. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-11 · Cited by 82
Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain
Rubió‐Casadevall, J., Marcos‐Gragera, R., Ortiz, M., Miró, J., Vilardell, L., Gironès, J., Hernández‐Yagüe, X., Cazador, A. C., Bernadó, L., Izquierdo, Á., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.07.015 · Cited by 82
Self-citationBlay, J. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.11.003 · Cited by 73
Cancer incidence in people with AIDS in Italy
Polesel, J., Franceschi, S., Suligoi, B., Crocetti, E., Falcini, F., Guzzinati, S., Vercelli, M., Zanetti, R., Tagliabue, G., Russo, A. G., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25153 · Cited by 68
Self-citationAge-Period-Cohort Analysis of Primary Bone Cancer Incidence Rates in the United States (1976–2005)
Anfinsen, K. P., Devesa, S. S., Bray, F., Troisi, R. J., Jónasdóttir, T. J., Bruland, Ø. S., & Grotmol, T. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0136 · Cited by 65
Stiller, C. A., Passmore, S. J., Kroll, M. E., Brownbill, P. A., Wallis, J. C., & Craft, A. W. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602885 · Cited by 46
Self-citation
Cited by
Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy096 · Cited by 1,614
Self-citationSchöffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., Grignani, G., Camargo, V., Bauer, S., Rha, S. Y., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01283-0 · Cited by 778
Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy310 · Cited by 617
Self-citationStacchiotti, S., & Sommer, J. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71190-8 · Cited by 501
Callegaro, D., Miceli, R., Bonvalot, S., Ferguson, P., Strauss, D. C., Levy, A., Griffin, A., Hayes, A. J., Stacchiotti, S., Pechoux, C. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00010-3 · Cited by 478
Self-citation
Metadata
- Authors
- Stiller, C. A., Trama, A., Brewster, D. H., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos-Gragera, R., Visser, O., Serraino, D., Weiderpass, E., Dei Tos, A. P., & Ascoli, V.
- Venue
- Cancer Epidemiology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 38
- Issue
- 6
- Pages
- 670-678
- ISSN
- 1877-7821 (ISSN-L)
- OpenAlex
- W2088303301
- Cited by
- 463
- References
- 38
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.